Abeo-HHC acetate
Synthetic cannabinoid
Abeo-HHC acetate | |
---|---|
![]() | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | 71902-08-4 |
PubChem | 3080631 |
DrugBank | |
ChemSpider | 2338855 |
KEGG |
Abeo-HHC acetate is a synthetic cannabinoid derivative that is structurally related to hexahydrocannabinol (HHC). It is a chemical compound that has been studied for its potential effects on the endocannabinoid system.
Chemical Structure[edit | edit source]
Abeo-HHC acetate is characterized by its unique chemical structure, which includes a hexahydrobenzo[c]chromene core. The compound is an acetate ester of abeo-hexahydrocannabinol, which means it has an acetyl group attached to the hydroxyl group of the cannabinoid.
Pharmacology[edit | edit source]
Abeo-HHC acetate interacts with the cannabinoid receptors in the central nervous system. These receptors, primarily CB1 and CB2, are part of the endocannabinoid system, which plays a role in regulating various physiological processes such as mood, appetite, and pain sensation.
Synthesis[edit | edit source]
The synthesis of Abeo-HHC acetate involves the chemical modification of hexahydrocannabinol. The process typically includes the acetylation of the hydroxyl group, resulting in the formation of the acetate ester. This modification can alter the pharmacokinetic properties of the compound, potentially affecting its potency and duration of action.
Potential Applications[edit | edit source]
Research into Abeo-HHC acetate is ongoing, with studies exploring its potential therapeutic applications. Like other cannabinoids, it may have potential uses in the treatment of conditions such as chronic pain, inflammation, and neurological disorders. However, more research is needed to fully understand its effects and safety profile.
Legal Status[edit | edit source]
The legal status of Abeo-HHC acetate varies by jurisdiction. In some regions, it may be classified as a controlled substance due to its structural similarity to other cannabinoids. Researchers and manufacturers must comply with local regulations when working with this compound.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD